The influence of the Korean traditional Chungkookjang on variables of metabolic syndrome in overweight/obese subjects: study protocol

BMC Complementary and Alternative Medicine

Tae-Sun Park¹  Youn-Soo Cha⁴  Seong-Yeop Jeong⁵  Do-Youn Jeong⁵  Moon-Sun Byun⁴  Ok-Kyeong Yu⁴  Min-Gul Kim³  Hye-Mi Kim²  Ki-Chan Ha²  Hyang-Im Back² 

[1]Department of Endocrinology and Metabolism, Chonuk National University, Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk 561-712, Republic of Korea

[2]Department of Medical Nutrition Therapy, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk 561-756, Republic of Korea

[3]Clinical Trial Center, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk 561-712, Republic of Korea

[4]Obesity Research Center, Chonbuk National University, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk 561-756, Republic of Korea

[5]Sunchang Research Center for Fermentation Microbes, 61-27 Minsongmaeul-gil, Sunchang-eup, Sunchang, Jeonbuk 595-804, Republic of Korea

关键词: Diabetes;    Obesity;    Overweight;    Metabolic syndrome;    Chungkookjang;   

Others  :  1220834
DOI  :  10.1186/1472-6882-13-297

 received in 2013-09-13, accepted in 2013-10-24,  发布年份 2013

【 摘 要 】

Background

Metabolic syndrome is a set of disorders that increases the risk of developing cardiovascular disease. The primary target of treatment of patients with metabolic syndrome is therapeutic lifestyle change. Numerous preclinical study have reported positive effects of chungkookjang in in vivo models of diabetes and obesity, but there is a paucity of controlled clinical trials on variables of metabolic syndrome in obese subjects. Thus, the objective of this trial is to examine the effect of chungkookjang compared to placebo on variables of metabolic syndrome in overweight/obese subjects.

Methods

This double-blind randomized controlled crossover trial will be conducted on 120 overweight/obese subjects; aged 19–29 years. Subjects will be recruited from the Chonbuk National University, Jeonju, South Korea. Enrolled subjects will be randomly assigned to two groups of equal number; one group received 35 g of chungkookjang (n = 60) and the other group received placebo (n = 60) on a regular daily basis for 12 weeks. After a 12-week washout period, the groups will be crossed over. In addition to anthropometric measures and blood pressure, glucose parameter, lipid profile, adipocytokine, and carnitine assay will be determined at baseline and 12 week. Also, safety will be assessing by measuring total bilirubin, alkaline phosphatase, alanine transaminase, aspartate aminotransferase, total protein, albumin, blood urea nitrogen, creatinine, and creatine kinase at baseline and 12 weeks. 24-hour dietary recalls were collected at the baseline and at the end of the trial.

Discussion

This trial will evaluate the effects of chungkookjang on variables of metabolic syndrome in overweight/obese subjects. The results of this study may contribute to the reduction of risk factor for metabolic syndrome caused by obesity.

Trial registration

Clinical trials NCT01811511.

【 授权许可】

   
2013 Back et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Withrow D, Alter DA: The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obesity Rev 2011, 12(2):131-141.
• [2]Flegal KM, Carroll MD, Kit BK, Ogden CL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012, 307(5):491-497.
• [3]Choi H, Song S, Kim J, Chung J, Yoon J, Paik HY, Song Y: High carbohydrate intake was inversely associated with high-density lipoprotein cholesterol among Korean adults. Nutrition Res 2012, 32(2):100-106.
• [4]Park SS, Yoon YS, Oh SW: Health-related quality of life in metabolic syndrome: The Korea National Health and Nutrition Examination Survey 2005. Diabetes Res Clin Pract 2011, 91:381-388.
• [5]Bitsori M, Kafatos A: Dysmetabolic syndrome in childhood and adolescence. Acta paediatrica 2005, 94(8):995-1005.
• [6]Cruz ML, Goran MI: The metabolic syndrome in children and adolescents. Curr Diab Reports 2004, 4(1):53-62.
• [7]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research G: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Eng J Med 2002, 346(6):393-403.
• [8]Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, Philippides G, Rocchini A, Council on Clinical Cardiology AHAECR, Prevention C, et al.: Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009, 119(25):3244-3262.
• [9]Nanri A, Mizoue T, Takahashi Y, Kirii K, Inoue M, Tsugane S, MN: Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J Nutr 2010, 140:580-586.
• [10]Kwon SH, Lee KB, Im KS, Kim SO, Park KY: Weight reduction and lipid lowering effects of Korean traditional soybean fermented products. J Korean Soc Food Sci Nutr 2006, 35(9):1194-1199.
• [11]Lee CU, Koh JB: Effects of Cheonggukjang on lipid metabolism in female rats fed cholesterol diet. J Life Sci 2006, 16:932-937.
• [12]Yang HJ, Kim HJ, Kim MJ, Kang S, da Kim S, Daily JW, Jeong do Y, Kwon DY, Park S: Standardized chungkookjang, short-term fermented soybeans with Bacillus lichemiformis, improves glucose homeostasis as much as traditionally made chungkookjang in diabetic rats. J Clin Biochem Nutr 2013, 52(1):49-57.
• [13]Kwon DY, Daily JW 3rd, Kim HJ, Park S: Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res 2010, 30(1):1-13.
• [14]Choi YH, Lim H, Heo MY, Kwon DY, Kim HP: Anti-inflammatory activity of the ethanol extract of Chungkukjang, Korean fermented bean: 5-lipoxygenase inhibition. J Med Food 2008, 11(3):539-543.
• [15]Kim DJ, Jeong YJ, Kwon JH, Moon KD, Kim HJ, Jeon SM, Lee MK, Park YB, Choi MS: Beneficial effect of chungkukjang on regulating blood glucose and pancreatic beta-cell functions in C75BL/KsJ-db/db mice. J Med Food 2008, 11(2):215-223.
• [16]Kwon DY, Hong SM, Lee JE, Sung SR, Park S: Long-term consumption of fermented soybean-derived Chungkookjang attenuates hepatic insulin resistance in 90% pancreatectomized diabetic rats. Horm Metab Res 2007, 39(10):752-757.
• [17]Kwon DY, Jang JS, Hong SM, Lee JE, Sung SR, Park HR, Park S: Long-term consumption of fermented soybean-derived Chungkookjang enhances insulinotropic action unlike soybeans in 90% pancreatectomized diabetic rats. Eur J Nutr 2007, 46(1):44-52.
• [18]Kwon DY, Jang JS, Lee JE, Kim YS, Shin DH, Park S: The isoflavonoid aglycone-rich fractions of Chungkookjang, fermented unsalted soybeans, enhance insulin signaling and peroxisome proliferator-activated receptor-gamma activity in vitro. Bio Factors 2006, 26(4):245-258.
• [19]Back HI, Kim SR, Yang JA, Kim MG, Chae SW, Cha YS: Effects of Chungkookjang supplementation on obesity and atherosclerotic indices in overweight/obese subjects: a 12-week, randomized, double-blind, placebo-controlled clinical trial. J Med Food 2011, 14(5):532-537.